The article focuses on the Personalized OncoGenomics (POG) initiative that offers individualized treatment plans. It mentions role of the initiative in cancer-care process which includes acquisition of biopsy sample to pathologic interpretation and treatment decisions. It highlights opportunities to perform groundbreaking research in genomic pathology.